MENU
OTLK
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Outlook Therapeutics (OTLK) Earnings Date & Reports

Outlook Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing ONS-5010, a monoclonal antibody, or mAb, for various ophthalmic indications... Show more

Industry: #Biotechnology
A.I. Advisor
published Earnings

OTLK is expected to report earnings to fall 46.67% to -7 cents per share on December 18

Outlook Therapeutics OTLK Stock Earnings Reports
Q3'26
Est.
$-0.08
Q2'26
Beat
by $0.11
Q1'26
Beat
by $0.27
Q4'25
Missed
by $0.32
Q3'25
Missed
by $0.22
The last earnings report on August 14 showed earnings per share of -15 cents, beating the estimate of -25 cents. With 3.46M shares outstanding, the current market capitalization sits at 106.24M.